Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM)

This study has been completed.
Information provided by National Heart, Lung, and Blood Institute (NHLBI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Arrhythmia
			Atrial Fibrillation
			Cardiovascular Diseases
			Heart Diseases
2		Additional conditions recognized in this trial
			Arrhythmias, Cardiac
3		More general conditions related to this trial
			Pathologic Processes
4		Interventions listed in this trial
			amiodarone
			sotalol
			propafenone
			flecainide
			quinidine
			moricizine
			disopyramide
			procainamide
			adrenergic beta antagonists
			verapamil
			diltiazem
			digoxin
			catheter ablation
			pacemaker, artificial
5		More general drug interventions related to this trial
			Adrenergic Agents
			Adrenergic alpha-Antagonists
			Adrenergic Antagonists
			Anti-Arrhythmia Agents
			Anti-Infective Agents
			Antimalarials
			Antiparasitic Agents
			Antiprotozoal Agents
			Cardiovascular Agents
			Cholinergic Agents
			Cholinergic Antagonists
			Enzyme Inhibitors
			Molecular Mechanisms of Pharmacological Action
			Muscarinic Antagonists
			Neurotransmitter Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
			Vasodilator Agents
6		Sponsors listed in this trial
			National Heart, Lung, and Blood Institute (NHLBI)